Beyond Borders: The Global Biotechnology Report 2006
(2006)
This year’s report covers developments across the globe. In the Americas, the U.S. industry is experiencing a third year of strong financial performance, product approvals, and financing – and is delivering strength and stability to investors. The European sector is back on track, as it comes out of a prolonged consolidation period and raises more funds that it has in years. And across the Asia-Pacific region, the focus is emerging as governments and companies are using biotechnology to fuel economic development. As always, the report is rich with data illustrating key trends and drivers. The global section of the report highlights the industry’s long-term accomplishments and considers what lies ahead. George Rathmann, a founding father of the industry, and Fred Frank, the banker behind the Roche-Genentech deal, look back on the evolution of the biotechnology and pharmaceutical sectors. A timeline and retrospective article identify key milestones and phases in industry growth. Wayne Hockmeyer highlights an issue central to biotechnology’s future – product pricing. A panel of industry experts looks even further, and considers what biotechnology may achieve 30 years from now.
Herausgeber : Ernst & Young
Organisation : Ernst & Young
